ONCOGENEX PHARMACEUTICALS IN
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for ONCOGENEX PHARMACEUTICALS IN COM, CUSIP 68230A10 .
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for ONCOGENEX PHARMACEUTICALS IN COM, CUSIP 68230A10 .